Latest filing published 28 Feb 2017 for Oncopeptides AB, €11k.
Filing timeline
BuySaleInsider track record
No signal scores available.
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
William Hulme: trading record in brief
All filings by William Hulme on record concern Oncopeptides AB. Between 21 February 2017 and 24 February 2017, the trades on record add up to 3 filings.
No open-market sale appears; the market trades are 2 purchases worth €117k. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant.
The newest entry dates from 28 February 2017: an open-market purchase of €11k, in Oncopeptides AB. The median gap between a trade and its publication by Finansinspektionen is 3 days. For comparison, MAR article 19 gives managers three business days to notify a trade. These figures are compiled from regulatory filings published by Finansinspektionen. They describe what insiders did and are not a recommendation.
Companies and markets linked to William Hulme
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 2,400 shares@ SEK 43.50ISIN SE0009414576FI:csv-86fc67cb3291f2a873d5Canonical exit: 25 May 2017 (T+90)
- 21,152 shares@ SEK 46.00ISIN SE0009414576FI:csv-67ede5cd1f6be37e617f
- 21,740 shares@ SEK 46.00ISIN SE0009414576FI:csv-4384b9f8f55a2ac81de3Canonical exit: 23 May 2017 (T+90)
3 of 3 declarations